Alaunos Therapeutics, Inc. (TCRT)
NASDAQ: TCRT · Real-Time Price · USD
2.600
+0.010 (0.39%)
Apr 29, 2026, 11:44 AM EDT - Market open
Alaunos Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -4.18 | -4.68 | -35.14 | -37.73 | -78.75 | |
| Depreciation & Amortization | 0.01 | 0 | 2.32 | 2.76 | 2.6 | |
| Other Amortization | - | - | 1.34 | 0.98 | 0.38 | |
| Loss (Gain) From Sale of Assets | - | - | 0.01 | 0.01 | - | |
| Asset Writedown & Restructuring Costs | - | - | 4.8 | - | 0.74 | |
| Stock-Based Compensation | 0.41 | 0.44 | 2.8 | 3.53 | 10.77 | |
| Other Operating Activities | 0.41 | - | -0.01 | 0.35 | -0.35 | |
| Change in Accounts Receivable | 0 | -0 | 0 | 1.11 | 3.56 | |
| Change in Accounts Payable | 0.1 | -0.1 | -0.77 | -0.03 | 0.27 | |
| Change in Other Net Operating Assets | 0.37 | -0.63 | -5.48 | -0.21 | -0.69 | |
| Operating Cash Flow | -2.87 | -4.97 | -30.14 | -29.23 | -61.47 | |
| Capital Expenditures | -0.1 | - | -0.2 | -0.22 | -3.32 | |
| Sale of Property, Plant & Equipment | - | - | 1.54 | 0.02 | - | |
| Investing Cash Flow | -0.1 | - | 1.35 | -0.19 | -3.32 | |
| Long-Term Debt Issued | - | - | - | - | 25 | |
| Long-Term Debt Repaid | - | - | -18.23 | -8.33 | - | |
| Net Debt Issued (Repaid) | - | - | -18.23 | -8.33 | 25 | |
| Issuance of Common Stock | 1.91 | - | 0.09 | 14.75 | 1.04 | |
| Repurchase of Common Stock | - | - | - | -0.05 | - | |
| Other Financing Activities | - | - | - | - | -0.26 | |
| Financing Cash Flow | 3.26 | - | -18.14 | 6.37 | 25.78 | |
| Net Cash Flow | 0.29 | -4.97 | -46.93 | -23.06 | -39.02 | |
| Free Cash Flow | -2.97 | -4.97 | -30.34 | -29.45 | -64.79 | |
| Free Cash Flow Margin | -59340.00% | -49710.00% | -606780.00% | -1007.80% | -16279.15% | |
| Free Cash Flow Per Share | -1.52 | -3.10 | -18.97 | -20.34 | -45.33 | |
| Cash Interest Paid | - | - | 2.06 | 2.17 | 0.63 | |
| Levered Free Cash Flow | -0.75 | -3.3 | -5.1 | -27.95 | -33.39 | |
| Unlevered Free Cash Flow | -0.75 | -3.3 | -5.24 | -26.96 | -33.03 | |
| Change in Working Capital | 0.47 | -0.73 | -6.25 | 0.87 | 3.14 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.